Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.09M Buy
206,096
+17,443
+9% +$108K ﹤0.01% 2550
2025
Q4
$1.46M Buy
188,653
+7,457
+4% +$66.5K ﹤0.01% 2428
2025
Q3
$1.6M Sell
181,196
-198,385
-52% -$1.48M ﹤0.01% 2394
2025
Q2
$1.58M Buy
379,581
+328,948
+650% +$2.06M ﹤0.01% 2407
2025
Q1
$305K Hold
50,633
﹤0.01% 3040
2024
Q4
$262K Buy
50,633
+16,234
+47% +$63.9K ﹤0.01% 3153
2024
Q3
$103K Hold
34,399
﹤0.01% 3307
2024
Q2
$103K Buy
+34,399
New +$284K ﹤0.01% 3305
2022
Q2
Sell
-42,697
Closed -$651K 3496
2022
Q1
$651K Buy
42,697
+634
+2% +$10.9K ﹤0.01% 2938
2021
Q4
$1.12M Sell
42,063
-3,442
-8% -$109K ﹤0.01% 2823
2021
Q3
$1.51M Sell
45,505
-5,881
-11% -$216K ﹤0.01% 2805
2021
Q2
$2.51M Sell
51,386
-6,852
-12% -$286K ﹤0.01% 2602
2021
Q1
$1.73M Sell
58,238
-2,464
-4% -$69K ﹤0.01% 2687
2020
Q4
$1.55M Buy
60,702
+2,052
+3% +$41.2K ﹤0.01% 2633
2020
Q3
$851K Buy
58,650
+226
+0.4% +$3.74K ﹤0.01% 2751
2020
Q2
$1.21M Buy
+58,424
New +$1.55M ﹤0.01% 2548

Other funds holding VSTM

Nuveen's VSTM Position: Q1 2026 in Review

Nuveen increased its Verastem (VSTM) stake by 9.2% in Q1 2026, buying an estimated $108K and bringing the position to 206,096 shares worth $1.09M. The position accounts for ﹤0.01% of the portfolio, ranked #2550.

Nuveen first reported a position in VSTM in Q2 2020 and has held it in 16 quarters since. The position peaked at $2.51M in Q2 2021. 155 funds tracked by Wall St. Rank hold VSTM as of Q1 2026.

  • Nuveen held 206,096 shares of Verastem worth $1.09M as of Q1 2026.
  • Nuveen bought 17,443 Verastem shares in Q1 2026, an estimated $108K.
  • Verastem made up ﹤0.01% of Nuveen's portfolio in Q1 2026, its #2550 holding.
  • Nuveen first reported a position in Verastem in Q2 2020 and has held it in 16 quarters since.
  • Nuveen's Verastem position peaked at $2.51M in Q2 2021.
  • 155 funds tracked by Wall St. Rank held Verastem as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.